Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Current Opinion in Oncology|July 15, 2024
Treatment approaches for older Hodgkin lymphoma patientsPaul J BröckelmannBritish Journal of Haematology|May 17, 2024
Considerations for anti-PD1-based first-line treatment of Hodgkin lymphomaPaul J BröckelmannCurrent Hematologic Malignancy Reports|May 30, 2015
The GHSG Approach to Treating Hodgkin's LymphomaPaul J Bröckelmann, Andreas EngertF1000Research|November 27, 2018
Moving things forward in Hodgkin lymphomaPaul J Bröckelmann, Boris BöllOncology Research and Treatment|October 25, 2017
Checkpoint Inhibition in Hodgkin Lymphoma - a ReviewPaul J Bröckelmann, Andreas EngertBlood|November 1, 2025
Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?Christian P Jaworek, Paul J BröckelmannLeukemia & Lymphoma|June 1, 2016
Current and future immunotherapeutic approaches in Hodgkin lymphomaPaul J Bröckelmann, Peter Borchmann, Andreas EngertDeutsche Medizinische Wochenschrift (1946)|January 9, 2020
[Complete remission of Loeffler's endocarditis with Imatinib in a myeloid and lymphoid neoplasm associated with eosinophilia]Hendrik Wienemann, Paul J Bröckelmann, Matti AdamBlood|March 4, 2018
Balancing risk and benefit in early-stage classical Hodgkin lymphomaPaul J Bröckelmann, Stephanie Sasse, Andreas EngertExpert Review of Hematology|February 11, 2020
Toxicities of novel therapies for hematologic malignanciesFlorian Simon, Jorge Garcia Borrega, Paul J BröckelmannPageof 7